Answers are grounded in this paper and cite their sources.
Purpose The present, retrospective cohort study evaluated the efficacy of photobiomodulation (PBM) with LEDs to prevent and treat oral mucositis (OM) in pediatric patients receiving high doses of MTX, and the relationship of the occurrence of OM with laboratory parameters as possible risk factors for the development of OM. Methods The medical records of children who received high doses of MTX (> 2g/m2) and photobiomodulation with LEDs were reviewed. Development of OM, hepatic and renal function, hemogram, delayed MTX excretion, febrile neutropenia were analyzed. Results Only 28 cases of OM were observed in the 358 cycles of high-dose MTX analyzed. Oral mucositis was associated with low levels of hemoglobin (p < 0.0001), hematocrits (p < 0.0001), ALT (p < 0.0001), and AST (p = 0.002). The risk of developing OM was associated with AST (OR 7.24; 95%CI 2.56–20.45), urea (OR 6.95; 95%CI 1.49–32.42), hemoglobin (OR 6.04; 95%CI 2.33–15.64), and febrile neutropenia (OR 4.41; 95%CI 2.89–15.73). This risk increases when these parameters are associated. Conclusion The low incidence of mucositis, compared with the literature, indicates that PBM can prevent and reduce the severity of OM, as well as hospitalization time. The risk of OM development is associated with febrile neutropenia, hematological, and kidney and liver toxicity, with the risk increasing when these factors are associated.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2021) studied this question.